Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Comment on ‘visual snow syndrome and migraine: a review’

Eye volume 38, page 1021 (2024)Cite this article

Subjects

We were very interested to read this article on visual snow syndrome (VSS; ref. [1]). VSS is not widely recognised in the ophthalmic community, despite its primary symptoms being visual in nature.

The authors provide a detailed review of possible associations and point out that certain medications ‘can have a deleterious effect’. However, they seem to overlook a recent report in the literature suggesting that a common group of drugs could potentially be linked to VSS.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Silva EM, Puledda F. Visual snow syndrome and migraine: a review. Eye. 2023;37:2374–8.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Healy D, Mangin D, Lochhead J. Development and persistence of patient-reported visual problems associated with serotonin reuptake inhibiting antidepressants. Int J Risk Saf Med. 2022;33:37–47.

    Article  PubMed  Google Scholar 

  3. Martinotti G, Santacroce R, Pettorruso M, Montemitro C, Spano MC, Lorusso M, et al. Hallucinogen persisting perception disorder: etiology, clinical features, and therapeutic perspectives. Brain Sci. 2018;8:47.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Fraser CL. Visual snow: updates on pathology. Curr Neurol Neurosci Rep. 2022;22:209–17.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Burns C. Antidepressant prescribing increases by 35% in six years [Internet]. London: The Pharmaceutical Journal; c2022. [updated 2022 Jul 8; cited 2023 Oct 8]. Available from: https://pharmaceutical-journal.com/article/news/antidepressant-prescribing-increases-by-35-in-six-years.

Download references

Author information

Authors and Affiliations

  1. St Mary’s Hospital, Parkhurst Road, Newport, Isle of Wight, PO30 5TG, UK

    Hannaa Bobat & Jonathan Lochhead

  2. North Wales Department of Psychological Medicine, Hergest Unit, Ysbyty Gwynedd, Bangor, Gwynedd, Wales, LL57 2PW, UK

    David Healy

Authors
  1. Hannaa Bobat
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David Healy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jonathan Lochhead
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

HB wrote and edited the manuscript. DH collected the data and reviewed the manuscript. JL conceived the idea and contributed to writing and editing the manuscript.

Corresponding author

Correspondence to Hannaa Bobat.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bobat, H., Healy, D. & Lochhead, J. Comment on ‘visual snow syndrome and migraine: a review’. Eye 38, 1021 (2024). https://doi.org/10.1038/s41433-023-02789-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41433-023-02789-1

This article is cited by

Search

Advanced search

Quick links